tonixpharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TNXP
Tonix Pharmaceuticals (TNXP) minimizes risks through a diversified development pipeline in the fields of infectious diseases and neuropathic pain. Current EBITDA levels clearly demonstrate the volatility of operating cash flows, where the current value is 0.00. Profit growth is based on preparations to launch fibromyalgia treatments to market. Massive demand potential in the US promises the company a rapid expansion of its customer base.
Tonix Pharmaceuticals Holding Corp. - rincian analitis lan metrik utama (TNXP)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Tonix Pharmaceuticals|TNXP - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Tonix Pharma|TNXP - Utang perusahaan|Utang-utang marang nilai buku Tonix Pharmaceuticals|TNXP - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Tonix Pharmaceuticals|Koefisien jangkoan perantara tonixpharma.com
- statistik bathi lan rasio pasar:
TNXP - Penghasilan resik|Prakiraan bathi resik Tonix Pharmaceuticals|TNXP - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi tonixpharma.com|TNXP - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Tonix Pharmaceuticals|TNXP - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Tonix Pharmaceuticals|TNXP - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan tonixpharma.com|TNXP - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Tonix Pharmaceuticals
Analisis kabeh metrik perusahaan:Tonix Pharmaceuticals
This indicator measures real cash flow from core operations, allowing for an assessment of the business's ability to generate cash excluding financial and tax factors. The EBITDA_Co valuation analysis reveals the resilience of Tonix Pharmaceuticals (TNXP) operational processes to external shocks, which is critical for a company with a volatile reputation and a dependence on clinical trial results amid frequent secondary offerings.
Pesaing Tonix Pharmaceuticals (TNXP)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Galapagos - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ANIP (ANI Pharmaceuticals Inc)|MNKD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Amphastar Corp|Pacira BioSciences (PCRX) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi SPRY|TBPH (Theravance Biopharma, Inc.) - Bathi operasional EBITDA|Aquestive Therapeutics Inc (AQST) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi SCPH (scPharmaceuticals Inc.)|tectonictx.com - Bathi operasional sadurunge amortisasi|China SXT Pharmaceuticals, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi EPRX|BHST - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi EXOZ|ORMP: Bathi operasional EBITDA|Entera Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|HYFT (MindWalk Holdings) - Bathi operasional EBITDA|Bathi operasional EBITDA abvcpharma.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FibroGen Corp FGEN|TELO - Bathi operasional sadurunge ngurangi amortisasi|Rani Therapeutics Inc - Bathi operasional EBITDA|SNYR - Bathi operasional EBITDA|RLYB: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Lexaria Bioscience Corp.|PULM (Pulmatrix Corp) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Pheton PTHL|Bathi operasional sadurunge ngurangi amortisasi APM (Aptorum Group Limited)|Bathi operasional EBITDA lyratherapeutics.com (LYRA)|Impact BioMedical - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TNFA (TNF Pharmaceuticals Inc.)|cbdMD Corp - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi PainReform Corp PRFX|CYTO: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi lipella.com|OPTN (OptiNose) - Bathi operasional EBITDA|Bathi operasional EBITDA Pieris Pharmaceuticals Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi PTPI (Petros Pharma)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International QLI|Pendapatan operasional sadurunge ngurangi amortisasi acelyrin.com (SLRN)|TFFP: Bathi operasional sadurunge ngurangi amortisasi
